Author details

Full Name

Kathryn E Foulds

Affiliation

ORCID

Career Start Year

2002

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37483285	Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques.		2023
38042809	Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates.		2023
37986823	Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.	bioRxiv	2023
38076895	Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates.		2023
37861342	Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusions in Rhesus Macaques.		2023
36789423	Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques.		2023
36848985	Rhesus macaque Bcl-6/Bcl-xL B cell immortalization: Discovery of HIV-1 neutralizing antibodies from lymph node.		2023
37503026	RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways.		2023
34921774	Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung.	Cell	2022
35653196	mRNA-1273 vaccination protects against SARS-CoV-2-elicited lung inflammation in nonhuman primates.	JCI insight	2022
35447072	mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron.	Cell	2022
35935978	Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study.	Front Immunol	2022
36516269	A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates.	Sci Transl Med	2022
34986348	Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys.	Cell Rep	2022
34417590	mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.	Nature Immunology	2021
34075375	Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates.		2021
33907752	Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates.	bioRxiv	2021
33688652	Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates.		2021
34280415	Vaccine nanodiscs plus polyICLC elicit robust CD8+ T cell responses in mice and non-human primates.	Journal of Controlled Release	2021
33790899	Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates.	Frontiers in Immunology	2021
33826898	Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base.	Cell Reports	2021
33441427	Measurement of leukocyte trafficking kinetics in macaques by serial intravascular staining.	Science Translational Medicine	2021
34315825	Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates.	Science Translational Medicine	2021
34672695	Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine-boosted nonhuman primates.	Science	2021
34729558	Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway.	bioRxiv	2021
34551978	Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses.	Proceedings of the National Academy of Sciences of the United States of America	2021
34426813	Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates.	bioRxiv	2021
34529476	Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.	Science	2021
32722908	Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.	N Engl J Med	2020
31896599	Expression of CD40L by the ALVAC-Simian Immunodeficiency Virus Vector Abrogates T Cell Responses in Macaques.	J Virol	2020
32755575	Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature.	Cell Rep	2020
32522807	Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality.	Science Translational Medicine	2020
30943274	Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.	PLoS Pathog	2019
31852797	DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes.	Science Translational Medicine	2019
31882800	Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.	Sci Rep	2019
31615930	Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".	J Virol	2019
30429343	Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.	J Virol	2019
30429340	Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.	J Virol	2019
31139193	Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate.	Front Immunol	2019
31488690	Blocking Î±<sub>4</sub>Î²<sub>7</sub> integrin binding to SIV does not improve virologic control.	Science	2019
31123763	Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates.	Immunogenetics	2019
30681265	OMIP-052: An 18-Color Panel for Measuring Th1, Th2, Th17, and Tfh Responses in Rhesus Macaques.	Cytometry. Part A : the journal of the International Society for Analytical Cytology	2019
31365858	Monocytes Acquire the Ability to Prime Tissue-Resident T Cells via IL-10-Mediated TGF-Î² Release.	Cell Reports	2019
31348886	Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization.	Cell	2019
29785023	HIV vaccine candidate activation of hypoxia and the inflammasome in CD14<sup>+</sup> monocytes is associated with a decreased risk of SIV<sub>mac251</sub> acquisition.	Nat Med	2018
29867235	Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.	Nat Med	2018
30420505	Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.	Proc Natl Acad Sci U S A	2018
28289286	Early antibody therapy can induce long-lasting immunity to SHIV.	Nature	2017
28445724	Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.	Cell Rep	2017
28202751	Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses.	J Virol	2017